Sumie Kato
Santiago, RM, Chile
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
A sex-informed transcriptomic prognostic score for gynecologic cancers: Multiplatform validation and spatial characterization.
Journal: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
Published: August 21, 2025
Re-evaluating prognostic indicators: The critical role of body composition and gene expression in endometrial cancer outcomes.
Journal: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
Published: July 10, 2024
Cyclooxygenase-2 Blockade Is Crucial to Restore Natural Killer Cell Activity before Anti-CTLA-4 Therapy against High-Grade Serous Ovarian Cancer.
Journal: Cancers
Published: November 20, 2023
Body Composition and Metabolic Dysfunction Really Matter for the Achievement of Better Outcomes in High-Grade Serous Ovarian Cancer.
Journal: Cancers
Published: December 15, 2022
Patient inflammatory status and CD4+/CD8+ intraepithelial tumor lymphocyte infiltration are predictors of outcomes in high-grade serous ovarian cancer.
Journal: Gynecologic oncology
Published: June 12, 2018
The impact on high-grade serous ovarian cancer of obesity and lipid metabolism-related gene expression patterns: the underestimated driving force affecting prognosis.
Journal: Journal of cellular and molecular medicine
Published: June 10, 2017
Structural and functional identification of vasculogenic mimicry in vitro.
Journal: Scientific reports
Published: April 26, 2017
Diabetic concentrations of metformin inhibit platelet-mediated ovarian cancer cell progression.
Journal: Oncotarget
Published: July 27, 2016
Leptin stimulates migration and invasion and maintains cancer stem-like properties in ovarian cancer cells: an explanation for poor outcomes in obese women.
Journal: Oncotarget
Published: March 10, 2015
Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cells.
Journal: BMC cancer
Published: October 28, 2014
Last Updated: 09/26/2026